Angelika Leppert

Angelika Leppert is an accomplished financial executive with extensive experience in the biopharmaceutical and consulting sectors. Currently serving as Chief Financial Officer at KUPANDO GmbH since May 2020, Angelika leads financial strategies for a company focused on developing novel TLR 4/7 agonist therapies. Previous roles include Start-up Coach at BioM Biotech Cluster Development GmbH, where Angelika designed funding concepts and facilitated strategic workshops, and Management Consultant & Business Coach in a self-employed capacity, offering corporate finance and organizational development services. Angelika held leadership positions at Medigene AG, overseeing corporate finance and HR functions, and worked as a Senior Consultant at Roland Berger. Angelika's educational background includes a Diplom Kauffrau in Business Economics from the University of Regensburg and various specialized certifications in business coaching and corporate finance.